Chosen laboratory markers as a determinant of COVID-19 severity.
作者信息
Navolokin Ihor, Tuboltseva Oleksandra, Navolokina Alla
机构信息
School of Medicine, International European University, Kyiv, Ukraine.
Department of Public Health and Social Medicine, International European University, Kyiv, Ukraine.
出版信息
Cardiol J. 2022;29(6):1049-1050. doi: 10.5603/CJ.a2022.0099. Epub 2022 Nov 7.
Abstract
摘要
相似文献
1
Chosen laboratory markers as a determinant of COVID-19 severity.选择实验室指标作为新冠病毒疾病严重程度的决定因素。
Cardiol J. 2022;29(6):1049-1050. doi: 10.5603/CJ.a2022.0099. Epub 2022 Nov 7.
2
Development of an evaluation model to determine disease severity in COVID-19 using basic laboratory markers.利用基本实验室指标建立评估模型以确定COVID-19疾病严重程度
Int J Lab Hematol. 2022 Oct;44(5):e245-e249. doi: 10.1111/ijlh.13912. Epub 2022 Jun 16.
3
Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severity.危重症成年COVID-19患者的下呼吸道和血浆严重急性呼吸综合征冠状病毒2（SARS-CoV-2）RNA载量：与疾病严重程度生物标志物的关系
J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.05.036. Epub 2021 Jun 1.
4
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.在细胞因子释放综合征背景下 SARS-CoV-2 感染的诊断。
Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12.
5
Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection.粪便钙卫蛋白作为新型冠状病毒感染中疾病严重程度的潜在生物标志物。
J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.06.016. Epub 2022 Jun 26.
6
SARS-CoV-2 RNAaemia in children: An Iranian referral hospital-based study.儿童中 SARS-CoV-2 RNAaemia：伊朗转诊医院的一项研究。
J Med Virol. 2021 Sep;93(9):5452-5457. doi: 10.1002/jmv.27065. Epub 2021 May 15.
7
Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients.抗 SARS-CoV-2 IgG 反应是 COVID-19 患者结局的有力预测标志物。
J Adv Res. 2021 Nov 26;36:133-145. doi: 10.1016/j.jare.2021.11.014. eCollection 2022 Feb.
8
A Viewpoint on Potential Biomarkers for Infectious COVID-19 Severity: An Updated Literature Survey.关于感染性新冠病毒严重程度潜在生物标志物的观点：最新文献综述
Infect Disord Drug Targets. 2021;21(5):e270421186965. doi: 10.2174/1871526520666201019121230.
9
A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.一项关于 SARS-CoV-2 患者的荟萃分析确定了 D-二聚体、C 反应蛋白、淋巴细胞和中性粒细胞值的组合意义，作为疾病严重程度的预测指标。
Int J Lab Hematol. 2021 Apr;43(2):324-328. doi: 10.1111/ijlh.13354. Epub 2020 Oct 3.
10
Biomarkers for severe COVID-19.重症新型冠状病毒肺炎的生物标志物
EBioMedicine. 2021 Jun;68:103405. doi: 10.1016/j.ebiom.2021.103405. Epub 2021 May 25.
本文引用的文献
1
Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis.乳酸脱氢酶在 COVID-19 中的诊断价值：系统评价和荟萃分析。
Cardiol J. 2022;29(5):751-758. doi: 10.5603/CJ.a2022.0056. Epub 2022 Jun 28.
2
Implications of cardiac markers in risk-stratification and management for COVID-19 patients.心脏标志物对 COVID-19 患者风险分层和管理的影响。
Crit Care. 2021 Apr 26;25(1):158. doi: 10.1186/s13054-021-03555-z.
3
Post-COVID-19 heart syndrome.新冠后心脏综合征
Cardiol J. 2021;28(2):353-354. doi: 10.5603/CJ.a2021.0028. Epub 2021 Mar 1.
4
Lactate dehydrogenase level as a COVID-19 severity marker.乳酸脱氢酶水平作为新冠病毒疾病严重程度的标志物。
Am J Emerg Med. 2021 Jul;45:638-639. doi: 10.1016/j.ajem.2020.11.025. Epub 2020 Nov 15.
5
Cytokines as predictors of COVID-19 severity: evidence from a meta-analysis.细胞因子作为COVID-19严重程度的预测指标：一项荟萃分析的证据
Pol Arch Intern Med. 2021 Jan 29;131(1):98-99. doi: 10.20452/pamw.15685. Epub 2020 Nov 21.
6
Mild versus severe COVID-19: Laboratory markers.轻症与重症 COVID-19：实验室标志物。
Int J Infect Dis. 2020 Jun;95:304-307. doi: 10.1016/j.ijid.2020.04.061. Epub 2020 Apr 25.
7
COVID-19 challenge for modern medicine.现代医学面临的 COVID-19 挑战。
Cardiol J. 2020;27(2):175-183. doi: 10.5603/CJ.a2020.0055. Epub 2020 Apr 14.
8
COVID 19 a challenge for emergency medicine and every health care professional.新冠病毒病对急诊医学和每一位医疗保健专业人员来说都是一项挑战。
Am J Emerg Med. 2020 Oct;38(10):2232-2233. doi: 10.1016/j.ajem.2020.03.038. Epub 2020 Mar 24.
Zotero 插件